KMB
KMB
Kimberly-Clark CorporationIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $4.16B ▲ | $1.06B ▲ | $665M ▲ | 15.97% ▲ | $2 ▲ | $743M ▲ |
| Q4-2025 | $4.08B ▼ | $958M ▲ | $499M ▲ | 12.23% ▲ | $1.5 ▲ | $685M ▼ |
| Q3-2025 | $4.13B ▼ | $855M ▼ | $446M ▼ | 10.79% ▼ | $1.34 ▼ | $833M ▲ |
| Q2-2025 | $4.16B ▼ | $864M ▼ | $509M ▼ | 12.23% ▲ | $1.53 ▼ | $802M ▼ |
| Q1-2025 | $4.84B | $964M | $567M | 11.71% | $1.71 | $976M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $542M ▼ | $17.18B ▼ | $15.27B ▼ | $1.8B ▲ |
| Q4-2025 | $688M ▲ | $17.23B ▲ | $15.57B ▲ | $1.5B ▲ |
| Q3-2025 | $617M ▼ | $16.89B ▲ | $15.42B ▲ | $1.33B ▲ |
| Q2-2025 | $634M ▲ | $16.77B ▲ | $15.37B ▲ | $1.27B ▲ |
| Q1-2025 | $563M | $16.3B | $15.08B | $1.1B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $675M ▲ | $745M ▼ | $-355M ▲ | $-527M ▼ | $-142M ▼ | $321M ▼ |
| Q4-2025 | $510M ▲ | $972M ▲ | $-2.99B ▼ | $-141M ▼ | $71M ▲ | $575M ▼ |
| Q3-2025 | $454M ▼ | $708M ▼ | $312M ▲ | $1.18B ▲ | $-40M ▼ | $1.11B ▲ |
| Q2-2025 | $512M ▼ | $770M ▲ | $-193M ▼ | $-500M ▲ | $94M ▲ | $573M ▲ |
| Q1-2025 | $573M | $327M | $-119M | $-683M | $-458M | $123M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Adult care products | $490.00M ▲ | $490.00M ▲ | $490.00M ▲ | $480.00M ▼ |
Away from Home Professional Products | $470.00M ▲ | $470.00M ▲ | $210.00M ▼ | $460.00M ▲ |
Consumer tissue products | $1.00Bn ▲ | $1.04Bn ▲ | $450.00M ▼ | $1.04Bn ▲ |
Diapers | $1.77Bn ▲ | $1.69Bn ▼ | $1.68Bn ▼ | $1.70Bn ▲ |
Feminine care products | $410.00M ▲ | $430.00M ▲ | $420.00M ▼ | $450.00M ▲ |
International Family Care Professional IFP | $910.00M ▲ | $1.39Bn ▲ | $0 ▼ | $0 ▲ |
International Personal Care IPC | $2.02Bn ▲ | $3.06Bn ▲ | $0 ▼ | $0 ▲ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Kimberly-Clark Corporation's financial evolution and strategic trajectory over the past five years.
Kimberly-Clark benefits from powerful global brands, entrenched shelf space, and a highly cash-generative, defensive business model. Profit margins have improved over time despite revenue volatility, reflecting pricing power and tight cost control. The company produces strong operating and free cash flow, has modestly reduced net debt, and continues to grow retained earnings. Its strategic focus on digital tools, smart professional products, and sustainability-aligned innovation further supports its long-standing competitive position.
The main concerns center on revenue declines in the most recent years, very high leverage relative to equity, and signs of possible underinvestment. Liquidity is adequate but not generous, relying heavily on ongoing cash inflows. The apparent elimination of R&D and sharp drop in capex in the latest year may indicate a tilt toward short-term margin support at the expense of long-term growth and product renewal, unless explained by one-off or classification factors. Competitive pressure from global peers and private labels, combined with input cost volatility and evolving sustainability demands, adds to the risk backdrop.
Looking ahead, Kimberly-Clark appears positioned as a stable, cash-rich, defensive consumer company with strong brands but facing a balancing act between protecting margins and reigniting growth. If management executes on its stated investment plans in advanced manufacturing, digital capabilities, and sustainable innovation, that could help support volumes and brand strength over time. Conversely, if revenue softness persists and reinvestment remains constrained, the company could see gradual pressure on its market share and pricing power, even while near-term profitability remains respectable. Overall, the trajectory leans on how effectively Kimberly-Clark can translate its strategic innovation ambitions into sustained top-line growth without overstraining an already leveraged balance sheet.
About Kimberly-Clark Corporation
https://www.kimberly-clark.comKimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $4.16B ▲ | $1.06B ▲ | $665M ▲ | 15.97% ▲ | $2 ▲ | $743M ▲ |
| Q4-2025 | $4.08B ▼ | $958M ▲ | $499M ▲ | 12.23% ▲ | $1.5 ▲ | $685M ▼ |
| Q3-2025 | $4.13B ▼ | $855M ▼ | $446M ▼ | 10.79% ▼ | $1.34 ▼ | $833M ▲ |
| Q2-2025 | $4.16B ▼ | $864M ▼ | $509M ▼ | 12.23% ▲ | $1.53 ▼ | $802M ▼ |
| Q1-2025 | $4.84B | $964M | $567M | 11.71% | $1.71 | $976M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $542M ▼ | $17.18B ▼ | $15.27B ▼ | $1.8B ▲ |
| Q4-2025 | $688M ▲ | $17.23B ▲ | $15.57B ▲ | $1.5B ▲ |
| Q3-2025 | $617M ▼ | $16.89B ▲ | $15.42B ▲ | $1.33B ▲ |
| Q2-2025 | $634M ▲ | $16.77B ▲ | $15.37B ▲ | $1.27B ▲ |
| Q1-2025 | $563M | $16.3B | $15.08B | $1.1B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $675M ▲ | $745M ▼ | $-355M ▲ | $-527M ▼ | $-142M ▼ | $321M ▼ |
| Q4-2025 | $510M ▲ | $972M ▲ | $-2.99B ▼ | $-141M ▼ | $71M ▲ | $575M ▼ |
| Q3-2025 | $454M ▼ | $708M ▼ | $312M ▲ | $1.18B ▲ | $-40M ▼ | $1.11B ▲ |
| Q2-2025 | $512M ▼ | $770M ▲ | $-193M ▼ | $-500M ▲ | $94M ▲ | $573M ▲ |
| Q1-2025 | $573M | $327M | $-119M | $-683M | $-458M | $123M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Adult care products | $490.00M ▲ | $490.00M ▲ | $490.00M ▲ | $480.00M ▼ |
Away from Home Professional Products | $470.00M ▲ | $470.00M ▲ | $210.00M ▼ | $460.00M ▲ |
Consumer tissue products | $1.00Bn ▲ | $1.04Bn ▲ | $450.00M ▼ | $1.04Bn ▲ |
Diapers | $1.77Bn ▲ | $1.69Bn ▼ | $1.68Bn ▼ | $1.70Bn ▲ |
Feminine care products | $410.00M ▲ | $430.00M ▲ | $420.00M ▼ | $450.00M ▲ |
International Family Care Professional IFP | $910.00M ▲ | $1.39Bn ▲ | $0 ▼ | $0 ▲ |
International Personal Care IPC | $2.02Bn ▲ | $3.06Bn ▲ | $0 ▼ | $0 ▲ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Kimberly-Clark Corporation's financial evolution and strategic trajectory over the past five years.
Kimberly-Clark benefits from powerful global brands, entrenched shelf space, and a highly cash-generative, defensive business model. Profit margins have improved over time despite revenue volatility, reflecting pricing power and tight cost control. The company produces strong operating and free cash flow, has modestly reduced net debt, and continues to grow retained earnings. Its strategic focus on digital tools, smart professional products, and sustainability-aligned innovation further supports its long-standing competitive position.
The main concerns center on revenue declines in the most recent years, very high leverage relative to equity, and signs of possible underinvestment. Liquidity is adequate but not generous, relying heavily on ongoing cash inflows. The apparent elimination of R&D and sharp drop in capex in the latest year may indicate a tilt toward short-term margin support at the expense of long-term growth and product renewal, unless explained by one-off or classification factors. Competitive pressure from global peers and private labels, combined with input cost volatility and evolving sustainability demands, adds to the risk backdrop.
Looking ahead, Kimberly-Clark appears positioned as a stable, cash-rich, defensive consumer company with strong brands but facing a balancing act between protecting margins and reigniting growth. If management executes on its stated investment plans in advanced manufacturing, digital capabilities, and sustainable innovation, that could help support volumes and brand strength over time. Conversely, if revenue softness persists and reinvestment remains constrained, the company could see gradual pressure on its market share and pricing power, even while near-term profitability remains respectable. Overall, the trajectory leans on how effectively Kimberly-Clark can translate its strategic innovation ambitions into sustained top-line growth without overstraining an already leveraged balance sheet.

CEO
Michael D. Hsu
Compensation Summary
(Year 2025)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2014-11-03 | Forward | 1043:1000 |
| 1997-04-03 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 903
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
UBS
Neutral
Barclays
Equal Weight
B of A Securities
Buy
Wells Fargo
Equal Weight
Deutsche Bank
Hold
Piper Sandler
Overweight
Grade Summary
Showing Top 6 of 13
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:40.85M
Value:$3.99B
BLACKROCK INC.
Shares:31.39M
Value:$3.06B
BLACKROCK, INC.
Shares:30.2M
Value:$2.95B
Summary
Showing Top 3 of 2,652

